IP Library Granted Patent US 9,370,732
Granted Patent B2
US 9,370,732 · App. 14/181,656 · Granted Jun 21, 2016

Methods for purifying biological cells

Inventor: Douglas T. Gjerde (Saratoga, CA)
Assignee: Douglas T. Gjerde
B01D15/3809G01N1/405B01L3/0275G01N15/1463G01N2015/008G01N2015/1006G01N2035/0434G01N2035/1053
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,370,732
App. No.
14/181,656
Granted
Jun 21, 2016
Kind
B2
Abstract

This invention relates to devices and methods for purifying biological cells. For example, viable tumor, stem, immune and sperm cells can be purified from a complex biological sample using a pipette tip column. Methods of the invention can aid research, diagnosis and treatment of cancer.

Claims (27)

1. A method for purifying viable cells, comprised of:

a) providing at least one column, wherein the column is comprised of a packed bed of medium, wherein the packed bed of medium has a bed volume, wherein the packed bed of medium is retained between two frits, a lower frit and an upper frit, wherein the packed bed of medium is comprised of particles, wherein the particles are comprised of an affinity group, wherein the affinity group is an aptamer;

b) providing a biological sample comprised of viable cells, wherein the biological sample has a sample volume, wherein the sample volume is larger than the bed volume;

c) aspirating the biological sample through the column using bidirectional flow, wherein the sample is aspirated through the lower frit, into the packed bed of medium and then through the upper frit;

d) expelling the biological sample, wherein the biological sample is expelled through the upper frit, into the packed bed of medium and then through the lower frit;

e) repeating steps (c) and (d) multiple times, wherein the biological sample is not incubated on the column, whereby a portion of the viable cells are captured by the aptamer affinity groups on the particles in the packed bed of medium;

f) aspirating a wash solution through the column using bidirectional flow, wherein the wash solution is aspirated through the lower frit, into the packed bed of medium and then through the upper frit;

g) expelling the wash solution through the upper frit, into the packed bed of medium and then through the lower frit; and

h) eluting the cells by passing an eluent through the column, wherein the eluted cells are viable, wherein the method is at least partially performed by a timed computer-controlled program, and wherein the entire method is performed in less than one hour.

2. The method of claim 1 , wherein between steps (g) and (h), the captured cells are labeled with a dye on the column.

3. The method of claim 1 , wherein the column is a pipette tip.

4. The method of claim 1 , wherein the sample is comprised of biological fluids or tissue.

5. The method of claim 1 , wherein the viable cells in the biological sample are T cells.

6. The method of claim 1 , wherein the frits have a pore size, and wherein the pore size is small enough to contain the packed bed of medium but large enough for cells to pass through.

7. A method purifying viable cells, comprised of:

a) providing a at least one column, wherein the column is comprised of a packed bed of medium, wherein the packed bed of medium has a bed volume, wherein the packed bed of medium is retained between two frits, a lower frit and an upper frit, wherein the packed bed of medium is comprised of particles, wherein the particles are comprised of an affinity group, wherein the affinity group is an aptamer;

b) providing a biological sample comprised of viable cells, wherein the viable cells are not labeled with antibodies, wherein the biological sample has a sample volume, wherein the sample volume is larger than the bed volume;

c) aspirating the biological sample through the column using bidirectional flow, wherein the sample is aspirated through the lower frit, into the packed bed of medium and then through the upper frit;

d) expelling the biological sample, wherein the biological sample is expelled through the upper frit, into the packed bed of medium and then through the lower frit;

e) repeating steps (c) and (d) multiple times, wherein the biological sample is not incubated on the column, whereby a portion of the viable cells are captured on aptamer affinity groups on the particles in the packed bed of medium;

f) aspirating a wash solution through the column using bidirectional flow, wherein the wash solution is aspirated through the lower frit, into the packed bed of medium and then through the upper frit;

g) expelling the wash solution through the upper frit, into the packed bed of medium and then through the lower frit; and

h) eluting the cells by passing an eluent through the column, wherein the eluted cells are viable and wherein the method is at least partially performed by a timed computer-controlled program.

8. The method of claim 7 , wherein between steps (g) and (h), the captured cells are labeled with a dye on the column.

9. The method of claim 7 , wherein the column is a pipette tip.

10. The method of claim 7 , wherein cells in the sample is comprised of biological fluids or tissue.

11. The method of claim 7 , wherein the cells in the biological sample are T cells or sperm cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2016
From: GJERDE, DOUGLAS T.
To: GJERDE, DOUGLAS T.
Reel/Frame 038596/0705 →
Continuity (2)
Provisional Application 61765541 · Feb 15, 2013
Related Publication 20140234890A1 · Aug 21, 2014